Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lawsuit: Schering execs sat on Vytorin results
Fierce Pharma
Tuesday, October 13, 2009 - 6:27pm
tags:
Vytorin, Schering Plough, ENHANCE
Earnings Preview: Abbott Labs
Seeking Alpha
Tuesday, October 13, 2009 - 6:16pm
tags:
earnings, Abbott Laboratories
Johnson & Johnson: Senate health plan's proposed tax on medical device makers could cost jobs
Yahoo/AP
Tuesday, October 13, 2009 - 6:15pm
tags:
JNJ, medical devices, healthcare reform
J&J Needs to Get Drugged Up
Motley Fool
Tuesday, October 13, 2009 - 6:15pm
tags:
JNJ
Shire and Sandoz settle Adderall XR patent suits
Yahoo/AP
Tuesday, October 13, 2009 - 6:07pm
tags:
Shire, Sandoz, Adderall XR, generics
A Big Upgrade for Teva Pharmaceutical
Motley Fool
Tuesday, October 13, 2009 - 11:16am
tags:
Teva Pharmaceuticals, upgrades, generics
Cel-Sci's Mystery Booster Writes Again
TheStreet.com
Tuesday, October 13, 2009 - 10:23am
tags:
Cel-Sci
Roche To Give Genentech Employees More Options
Pharmalot
Tuesday, October 13, 2009 - 10:22am
tags:
Roche, Genentech, M&A
Novavax gets grant for respiratory virus vaccine
Yahoo/AP
Tuesday, October 13, 2009 - 10:20am
tags:
vaccines, Novavax, RSV
Opko agrees to deal with Schering-Plough
Bizjournals.com
Tuesday, October 13, 2009 - 10:19am
tags:
Schering Plough, OPKO Health, rolapitant
Why Other Drugmakers Want to Be More Like J&J
WSJ Online
Tuesday, October 13, 2009 - 10:18am
tags:
JNJ, earnings
J&J Shares Drop on Lackluster Earnings
TheStreet.com
Tuesday, October 13, 2009 - 9:58am
tags:
earnings, JNJ
Vanda's Fanapt Deal Just Okay
TheStreet.com
Tuesday, October 13, 2009 - 9:57am
tags:
Vanda, Fanapt, Novartis
Dyax says Sanofi-Aventis recently licensed eye drug and cancer drug from Dyax collaborators
Yahoo/AP
Tuesday, October 13, 2009 - 9:22am
tags:
Sanofi, Dyax
Top 15 Women in Pharma
Fierce Biotech
Tuesday, October 13, 2009 - 9:06am
tags:
women
J&J reports modestly higher earnings
Marketwatch
Tuesday, October 13, 2009 - 8:00am
tags:
JNJ, earnings
Pharma on Twitter: J&J Tweets the Most; Novartis Has Most Followers, Abbott Not Out of the Gate Yet
BNET Pharma
Tuesday, October 13, 2009 - 7:23am
tags:
twitter, social media
Glaxo to Spend Up to EU460 Million for Prosensa Drugs
Bloomberg
Tuesday, October 13, 2009 - 7:19am
tags:
GSK, M&A, Prosensa
Raptor shares rocket up on positive liver drug data
Fierce Biotech
Monday, October 12, 2009 - 8:53pm
tags:
Raptor Pharmaceuticals, Torrey Pines, drug trials
Mating Season for Drug Companies
Portfolio.com
Monday, October 12, 2009 - 8:49pm
tags:
M&A, ONYX Pharmaceuticals, Proteolix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.